Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2025-12-26 @ 11:32 PM
Study NCT ID:
NCT05824559
Status:
TERMINATED
Last Update Posted:
2024-11-21
First Post:
2023-03-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer
Sponsor:
MEI Pharma, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-23
Completion Date Type:
ACTUAL
First Submit Date:
2023-03-22
First Submit QC Date:
None
Study First Post Date:
2023-04-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-09-20
Results First Submit QC Date:
None
Results First Post Date:
2024-11-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-14
Last Update Post Date:
2024-11-21
Last Update Post Date Type:
ACTUAL